Eric R. Olson, Chief Scientific Officer at Syros Pharmaceuticals, Inc. (SYRS), sold 12,500 shares at $21.85 ($273K) on 2017-07-25, disclosed to the SEC on 2017-07-27.
Open-market sale of $273k SYRS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SYRS | SELL | 2021-07-01 | $6K | — | Filing → |
| SYRS | SELL | 2021-03-17 | $34K | — | Filing → |
| SYRS | SELL | 2020-08-19 | $205K | — | Filing → |